Common side effects include vomiting, diarrhea, headaches, and a rash. Severe side effects requiring hospitalization are rare, but include mental health problems such as depression, hallucinations, anxiety and neurological side effects such as poor balance, seizures, and ringing in the ears.<unk>  is therefore not recommended in people with a history of psychiatric disorders or epilepsy. Neurologic and psychiatric In 2013, the U.S. Food and Drug Administration (FDA) added a boxed warning to the prescription label of<unk>  regarding the potential for neuropsychiatric side effects that may persist even after discontinuing administration of the medication. In 2013 the FDA stated "Neurologic side effects can occur at any time during drug use, and can last for months to years after the drug is stopped or can be permanent." Neurologic effects include dizziness, loss of balance, seizures, and tinnitus. Psychiatric effects include nightmares, visual hallucinations, auditory hallucinations, anxiety, depression, unusual behavior, and suicidal ideations. Central nervous system events requiring hospitalization occur in about one in 10,000 people taking<unk>  for malaria prevention, with milder events (e.g., dizziness, headache, insomnia, and vivid dreams) in up to 25%. When some measure of subjective severity is applied to the rating of adverse events, about 11–17% of travelers are incapacitated to some degree. Cardiac<unk>  may cause abnormalities with heart rhythms that are visible on electrocardiograms. Combining<unk>  with other drugs that cause similar effects, such as quinine or quinidine, can increase these effects. Combining<unk>  with halofantrine can cause significant increases in QTc intervals.
Mefloquine
Primaquine
Artemether
Tafenoquine
Amodiaquine
Piperaquine
Chloroquine
Quinine